Prospective open label non-comparative study of the safety, efficacy and tolerability of high dose ritonavir/lopinavir [lopinavir/ritonavir; Kaletra] liquid in salvage therapy for PI [protease inhibitor] resistant HIV & a PK [pharmacokinetic] equivalence sub-study of high dose ritonavir/lopinavir capsules
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Antiretrovirals; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 23 Nov 2005 New trial record.